TWEAK and monocyte to HDL ratio as a predictor of metabolic syndrome in patients with polycystic ovary syndrome

References

• Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–1236.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE. ASRM-Sponsored, P. C. O. S: revised 2003 consensus on diagnostic criteria and long-term health risks related to polycysticovary syndrome (PCOS). Hum Reproduct. (Oxf, Engl) 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Rashidi H, Khomami MB, et al. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014;12:89.
   PubMed Web of Science ®Google Scholar
• Celik E, Turkcuoglu I, Ata B, et al. Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome. J Turkish German Gynecol Assoc. 2016;17:201.
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 2007;1:01–3670.
   Google Scholar
• Soares EM, Azevedo GD, Gadelha RG, et al. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008;89:649–655.
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Liljenquist DR, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2006;91:48–53.
   PubMed Web of Science ®Google Scholar
• Zahiri Z, Sharami SH, Milani F, et al. Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertil Steril. 2016;9:490.
   PubMed Web of Science ®Google Scholar
• Seeber B, Morandell E, Lunger F, et al. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol. 2014;12:88.
   PubMed Web of Science ®Google Scholar
• Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov. 2008;7:411–425.
   PubMed Web of Science ®Google Scholar
• Burkly LC, Michaelson JS, Hahm K, et al. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine. 2007;40:1–16.
   PubMed Web of Science ®Google Scholar
• Feng F, Wang L, Albanese N, et al. Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes. Endocrinology. 2008;149:1505–1513.
   PubMed Web of Science ®Google Scholar
• Blanco-Colio LM, Martin-Ventura JL, Munoz-Garcia B, et al. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:916–922.
   PubMed Web of Science ®Google Scholar
• Jelic-Ivanovic Z, Bujisic N, Spasic S, et al. Circulating sTWEAK improves the prediction of coronary artery disease. Clin Biochem. 2009;42:1381–1386.
   PubMed Web of Science ®Google Scholar
• Kralisch S, Ziegelmeier M, Bachmann A, et al. Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis. 2008;199:440–444.
   PubMed Web of Science ®Google Scholar
• Chorianopoulos E, Rosenberg M, Zugck C, et al. Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail. 2009;11:1050–1056.
   PubMed Web of Science ®Google Scholar
• Erkenekli K, Oztas E, Kuscu E, et al. Polycystic ovary syndrome and increased soluble tumor necrosis factor like weak inducer of apoptosis levels are independent predictors of dyslipidemia in youth. Gynecol Obstet Invest. 2017;82:200–204.
   PubMed Web of Science ®Google Scholar
• Ucar FM. A potential marker of bare metal stent restenosis: monocyte count-to-HDL cholesterol ratio. BMC Cardiovasc Disord. 2016;16:186.
   PubMed Web of Science ®Google Scholar
• Atan D, Kundi FCS, Özcan KM, et al. A new predictor for obstructive sleep apnea syndrome: monocyte to HDL ratio. Indian J Otolaryngol Head Neck Surg. 2017;69:142–146.
   PubMed Web of Science ®Google Scholar
• You S, Zhong C, Zheng D, et al. Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage. J Neurol Sci. 2017;372:157–161.
   PubMed Web of Science ®Google Scholar
• Xu X, Lai Y, Yang G, et al. Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome. Medicine (Baltimore) 2016;95:e5524.
   PubMed Web of Science ®Google Scholar
• Jain M, Jakubowski A, Cui L, et al. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation. 2009;119:2058–2068.
   PubMed Web of Science ®Google Scholar
• Justo P, Sanz AB, Sanchez NMD, et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 2006;70:1750–1758.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Carrero JJ, Ortiz A, et al. Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1716–1723.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Qureshi AR, Carrero JJ, et al. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol. 2010;31:214–221.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Tonbul HZ, Erdur FM, et al. Soluble TWEAK independently predicts atherosclerosis in renal transplant patients. BMC Nephrol. 2013;14:144.
   PubMed Web of Science ®Google Scholar
• Vázquez-Carballo A, Ceperuelo-Mallafré V, Chacón MR, et al. TWEAK prevents TNF-α-induced insulin resistance through PP2A activation in human adipocytes. Am J Physiol Endocrinol Metabol. 2013;305:E101–E112.
   PubMed Web of Science ®Google Scholar
• Simón‐Muela I, Llauradó G, Chacón MR, et al. Reduced circulating levels of TWEAK are associated with gestational diabetes mellitus. Eur J Clin Invest. 2015;45:27–35.
   PubMed Web of Science ®Google Scholar
• Cetin MS, Cetin EHO, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart, Lung Circulat. 2016;25:1077–1086.
   PubMed Web of Science ®Google Scholar